FEZF1 and gastric adenocarcinoma: For STAD diagnosis, the sensitivity and specificity of FEZF1-AS1 was 93.9% and 77.9% (Figure 7C); the sensitivity and specificity of HOTAIR was 87.9% and 87.7% (Figure 7E); the sensitivity and specificity of LINC01234 was 93.9% and 76.8% (Figure 7I), respectively.